HCPCS Level II code C1816 designates a receiver and/or transmitter component for an implantable neurostimulator, an essential device in neuromodulation therapies for chronic pain and other neurologic conditions. Nationally, accurate coding of implantable neurostimulator components affects device supply billing, hospital device inventory, and reimbursement alignment for surgical implantation and device management.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise outline of clinical context for C1816, typical sites of service, and which payers commonly adjudicate claims involving implantable neurostimulator components. The publication highlights benchmark topics such as allowable coding practices, payer coverage considerations, and common billing modifiers used with device supply lines. It also summarizes relevant policy updates and documentation expectations tied to neurostimulation device claims.

This summary equips coding professionals, billing managers, and clinical program leads with the information needed to identify C1816 on supply line items, understand the clinical setting where the code applies, and anticipate payer-specific coverage and claims processing themes for implantable neurostimulator hardware.